Exited the Aratana Therapeutics deal | Value Investing News

Exited the Aratana Therapeutics deal

  • Just one week ago I wrote that I initiated a position in Aratana Therapeutics (NASDAQ:PETX).
  • With Elanco now trading at $30.77/share and Aratana at $4.63/share the spread is a negative 1.6% and the CVR is implicitly valued at $0.07/share.
  • My rough, and perhaps optimistic guess, of its value was around $0.10/share so there is little reason to keep my Aratana position.
Rating: 
No votes yet
Article Link: 
Shared Count: 
0
Value Score: 
0
Category: